The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ERIC, AI and ABBV Pharmaceutical Investing
ABBV Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of June 6, 2022 Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
LAWSUITS FILED AGAINST MP, CRNC and AUPH - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS Pharmaceutical Investing
SHAREHOLDER ALERT: AI GRAB ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere myPath Digital Health App Pharmaceutical Investing
KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th Pharmaceutical Investing
Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance Pharmaceutical Investing
Aptose to Report First Quarter 2022 Financial Results and Hold Conference Call on Monday, May 9, 2022 Market News
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 at the American Society of Cataract and Refractive Surgery Annual Meeting Pharmaceutical Investing
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced, or High-Risk Early-Stage Triple-Negative Breast Cancer Life Science Investing
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022 Pharmaceutical Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
